Canaccord Genuity Maintains Hold on Staar Surgical, Lowers Price Target to $31
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity has maintained a Hold rating on Staar Surgical while lowering the price target from $41 to $31.
November 01, 2024 | 12:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Canaccord Genuity has maintained a Hold rating on Staar Surgical and reduced the price target from $41 to $31, indicating a more cautious outlook.
The reduction in price target from $41 to $31 by Canaccord Genuity suggests a less optimistic view on Staar Surgical's future performance, which could negatively impact the stock price in the short term. The Hold rating indicates that the analyst does not see significant upside potential at the moment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100